Emily Lee

Full contact info


Cytek Biosciences – $200 Million IPO

July 23, 2021

Cooley advised Cytek Biosciences on its $200 million initial public offering of 14,564,635 shares of common stock. Cytek Biosciences, whose securities now trade on the Nasdaq Global Select Market under the symbol CTKB, is a leading cell analysis solutions company. Partners Gordon Ho, Patrick Loofbourrow and John McKenna led the Cooley team.

Related contacts

Gordon Ho
Partner, Palo Alto
Patrick Loofbourrow
Partner, Singapore
John McKenna
Partner, Palo Alto
Samara Zaifman
Associate, Palo Alto
Emily Lee
Associate, Palo Alto
Christian Lee
Associate, San Francisco

Related Practices & Industries

Admissions & credentials